Advanced Risk Stratification in Non-Ischemic Cardiomyopathy: The Prognostic Role of Cardiac Magnetic Resonance
Journal of Clinical Medicine · 20.01.2026 · 15 (2) · 841
DOI: 10.3390/jcm15020841 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 20.01.2026. Verfasst von Guido Pastorini und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Division, Ospedale Regina Montis Regalis Strada del Rocchetto 99, ASLCN1, 12084 Mondovi, Italy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cardiac magnetic resonance (CMR) imaging has been considered crucial in non-ischemic cardiomyopathy (NICM). This study aims to evaluate the role of CMR in identifying risk factors for life-threatening events in patients with NICM and reduced left ventricular ejection fraction (LVEF).
Methods
We analysed 57 (mean age 62.5 ± 11.4 years, 68.4% male) first-diagnosed NICM patients with reduced LVEF (mean 42 ± 9%). CMR assessments evaluated LVEF, right ventricular ejection fraction (RVEF), cardiac T1 mapping, extracellular volume (ECV), and the presence/extension of late gadolinium enhancement (LGE). Patients were monitored for a composite endpoint including sudden cardiac death (SCD), major ventricular arrhythmic events, and hospitalization for heart failure (HHF).
Results
During a median follow-up lasting 543 days, 18 patients (31%) experienced cardiovascular events. A higher native T1 mapping value (1076 (1025–1120) ms vs. 999 (990–1037) ms, p < 0.001), a higher ECV (34 ± 6% vs. 28 ± 4,% p < 0.001) and a reduced RVEF (52 ± 13% vs. 60 ± 9%, p < 0.03) proved to be significantly correlated to an increased HHF, arrhythmic and SCD risk. Additionally, a native T1 mapping value exceeding 1018 ms demonstrated an increased risk (HR: 6.285; 95% CI: 2.044–19.326, p = 0.001) as well as an ECV greater than 28% (HR: 19.752; 95% CI: 2.622–148.817, p = 0.004) for composite endpoint.
Conclusion
In NICM patients, elevated native T1 mapping and ECV values identified a high-risk subgroup for arrhythmic events while LVEF, and RVEF provide further risk stratification for the composite endpoint. CMR assessment may optimize risk stratification in NICM patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiology Division, Ospedale Regina Montis Regalis Strada del Rocchetto 99, ASLCN1, 12084 Mondovi, Italy.
- Cardiology Division, Ospedale Dario Camberlingo, ASL, 72017 Brindisi, Italy.
- Cardiovascular Rehabilitation, Ospedale Fossano ASLCN1, 12045 Fossano, Italy.
ORCID-Profile: Guido Pastorini, Eleonora Indolfi, Fabio Anastasio, Mauro Feola
Zitieren
APA
Pastorini, G., Testa, M., Indolfi, E., Conte, E., Anastasio, F., & Feola, M. (2026). Advanced Risk Stratification in Non-Ischemic Cardiomyopathy: The Prognostic Role of Cardiac Magnetic Resonance. Journal of Clinical Medicine, 15(2), 841. https://doi.org/10.3390/jcm15020841
Vancouver
Pastorini G, Testa M, Indolfi E, Conte E, Anastasio F, Feola M. Advanced Risk Stratification in Non-Ischemic Cardiomyopathy: The Prognostic Role of Cardiac Magnetic Resonance. Journal of Clinical Medicine. 2026;15(2):841. doi:10.3390/jcm15020841
BibTeX
@article{Pastorini2026,
author = {Pastorini, Guido and Testa, Marzia and Indolfi, Eleonora and Conte, Enrica and Anastasio, Fabio and Feola, Mauro},
title = {Advanced Risk Stratification in Non-Ischemic Cardiomyopathy: The Prognostic Role of Cardiac Magnetic Resonance},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {2},
pages = {841},
doi = {10.3390/jcm15020841}
}
EUVIMED